Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16184
Title: | Randomised controlled trials of psychological & pharmacological treatments for body dysmorphic disorder: A systematic review | Austin Authors: | Phillipou, Andrea ;Rossell, Susan L;Wilding, Helen E;Castle, David J | Affiliation: | Austin Health, Heidelberg, Victoria, Australia Department of Psychiatry, St Vincent's Hospital, Fitzroy, Victoria, Australia Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia Department of Mental Health, Austin Health, Heidelberg, Victoria, Australia Brain & Psychological Sciences Research Centre, Swinburne University of Technology, Hawthorn, Victoria, Australia Monash Alfred Psychiatry Research Centre, Melbourne, Victoria, Australia Faculty of Health Sciences, Australian Catholic University, Fitzroy, Victoria, Australia |
Issue Date: | Nov-2016 | Date: | 2016-08-05 | Publication information: | Psychiatry research 2016; 245: 179-185 | Abstract: | Treatment for body dysmorphic disorder (BDD) often involves a combination of psychological and pharmacological interventions. However, only a small number of randomised controlled trials (RCTs) have been undertaken examining the efficacy of different therapeutic interventions. The aim of this study was to systematically review the RCTs involving psychological and pharmacological interventions for the treatment of BDD. The literature was searched to June 2015, and studies were included if they were written in English, empirical research papers published in peer-review journals, specifically assessed BDD patients, and involved a RCT assessing BDD symptoms pre- and post-intervention. Nine studies were identified: six involving psychological and three involving pharmacological interventions. Cognitive behaviour therapy, metacognitive therapy and selective serotonin reuptake inhibitors were identified as treatments with potential benefit. The small number of RCTs and the heterogeneity of findings emphasises the need for more high quality RCTs assessing both psychological and pharmacological interventions for BDD. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16184 | DOI: | 10.1016/j.psychres.2016.05.062 | Journal: | Psychiatry Research | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/27544783 | Type: | Journal Article | Subjects: | Cognitive therapy Body dysmorphic disorders Behaviour therapy Serotonin and noradrenaline reuptake inhibitors |
Type of Clinical Study or Trial: | Reviews/Systematic Reviews |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.